NK

Nagendra Kumar Vallamkonda

Active Director Director DIN 06742154
DIN 06742154 First appointment Oct 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Oct 2013
Shareholding value •••• Premium profile

About Nagendra Kumar Vallamkonda

Data last updated:

Nagendra Kumar Vallamkonda is a Director at Skandanana Pharma Private Limited (since 2020), Director at Sansec Pharma Solutions Private Limited (since 2018) and Designated Partner at Tanmayee Wellness Llp (since 2024), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹13.45 Cr; the largest is Skandanana Pharma Private Limited at ₹12.81 Cr (FY 2023). Earlier, Nagendra Kumar Vallamkonda was a Designated Partner at Skandana Life Sciences Llp (2023–2025) and Additional Director at Unisan Formulations Private Limited (2013–2016) and 1 more.

DIN 06742154
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2013
Oldest Company Age 8 yrs
Largest company Skandanana Pharma Private Limited · ₹12.81 Cr (FY 2023)
Combined revenue ₹13.45 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skandanana Pharma Private Limited U93000TG2020PTC140032
Director01 Apr 20202020₹12.81 Cr (FY 2023)Active
Director12 Mar 20182018₹64.3 Lakh (FY 2020)Active
Designated Partner13 Jun 20242024Active
Director18 Jul 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jun 20232023Active
Unisan Formulations Private Limited U24239TG2003PTC161277
Additional Director10 Oct 20132003₹1.15 Cr (FY 2020)Active
Svvs Cal Labs Private Limited U85100TG2021PTC152498
Director24 Jun 20212021₹2.08 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Nagendra Kumar Vallamkonda

Directorship timeline

Open interactive timeline →
Sansec Pharma Solutions Private Limited
Skandanan Infra Projects Private Limited
Skandanana Pharma Private Limited
Tanmayee Wellness Llp
Premium access

Shareholding and investment profile for Nagendra Kumar Vallamkonda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagendra Kumar Vallamkonda

Nagendra Kumar Vallamkonda currently holds 4 directorships: Skandanana Pharma Private Limited (Director, since 01 Apr 2020, revenue ₹12.81 Cr (FY 2023)); Sansec Pharma Solutions Private Limited (Director, since 12 Mar 2018, revenue ₹64.3 Lakh (FY 2020)); Tanmayee Wellness Llp (Designated Partner, since 13 Jun 2024); Skandanan Infra Projects Private Limited (Director, since 18 Jul 2022).

Nagendra Kumar Vallamkonda was first appointed on 10 Oct 2013 as Additional Director at Unisan Formulations Private Limited. The most recent appointment on record is 13 Jun 2024 at Tanmayee Wellness Llp.

The 2 current companies of Nagendra Kumar Vallamkonda that report revenue have a combined latest revenue of ₹13.45 Cr: Skandanana Pharma Private Limited ₹12.81 Cr (FY 2023); Sansec Pharma Solutions Private Limited ₹64.3 Lakh (FY 2020).

Nagendra Kumar Vallamkonda held 3 earlier board appointments: Skandana Life Sciences Llp (Designated Partner, 08 Jun 2023 to 15 Feb 2025); Unisan Formulations Private Limited (Additional Director, 10 Oct 2013 to 03 Apr 2016); Svvs Cal Labs Private Limited (Director, 24 Jun 2021 to 11 Dec 2022).

The current boards of Nagendra Kumar Vallamkonda's companies include Vallamkonda Lakshmi Sravani (Skandanana Pharma Private Limited), Padmavathi Kanduri (Sansec Pharma Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available